Literature DB >> 31106235

Murine Pharmacokinetic Studies.

Alix F Leblanc1, Kevin M Huang1, Muhammad Erfan Uddin1, Jason T Anderson1, Mingqing Chen1, Shuiying Hu1.   

Abstract

Murine pharmacokinetics (PK) represents the absorption, distribution, metabolism, and elimination of drugs from the body, which helps to guide clinical studies, ultimately resulting in more effective drug treatment. The purpose of this protocol is to describe a serial bleeding protocol, obtaining blood samples at six time points from single mouse to yield a complete PK profile. This protocol has proved to be rapid, highly repeatable, and relatively easy to acquire. Comparing with the conventional PK studies, this method not only dramatically reduces animal usage, but also decreases sample variation obtained from different animals.

Entities:  

Keywords:  Blood; Cardiac puncture; Orbital venous plexus; Pharmacokinetic; Plasma; Submandibular vein

Year:  2018        PMID: 31106235      PMCID: PMC6521687          DOI: 10.21769/BioProtoc.3056

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  5 in total

Review 1.  Snapshot PK: a rapid rodent in vivo preclinical screening approach.

Authors:  Bo Liu; Jonathan Chang; William P Gordon; John Isbell; Yingyao Zhou; Tove Tuntland
Journal:  Drug Discov Today       Date:  2007-11-26       Impact factor: 7.851

2.  Simultaneous pharmacokinetic screening of a mixture of compounds in the dog using API LC/MS/MS analysis for increased throughput.

Authors:  J Berman; K Halm; K Adkison; J Shaffer
Journal:  J Med Chem       Date:  1997-03-14       Impact factor: 7.446

3.  Cassette-accelerated rapid rat screen: a systematic procedure for the dosing and liquid chromatography/atmospheric pressure ionization tandem mass spectrometric analysis of new chemical entities as part of new drug discovery.

Authors:  W A Korfmacher; K A Cox; K J Ng; J Veals; Y Hsieh; S Wainhaus; L Broske; D Prelusky; A Nomeir; R E White
Journal:  Rapid Commun Mass Spectrom       Date:  2001       Impact factor: 2.419

4.  Fast mouse PK (Fast PK): a rapid screening method to increase pharmacokinetic throughput in pre-clinical drug discovery.

Authors:  Jitendar Reddy; Sreedhar Madishetti; Prakash R Vachaspati
Journal:  Eur J Pharm Sci       Date:  2012-07-09       Impact factor: 4.384

5.  OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity.

Authors:  Alix F Leblanc; Jason A Sprowl; Paola Alberti; Alessia Chiorazzi; W David Arnold; Alice A Gibson; Kristen W Hong; Marissa S Pioso; Mingqing Chen; Kevin M Huang; Vamsi Chodisetty; Olivia Costa; Tatiana Florea; Peter de Bruijn; Ron H Mathijssen; Raquel E Reinbolt; Maryam B Lustberg; Lara E Sucheston-Campbell; Guido Cavaletti; Alex Sparreboom; Shuiying Hu
Journal:  J Clin Invest       Date:  2018-01-16       Impact factor: 14.808

  5 in total
  13 in total

1.  Pharmacokinetics of Sustained-release and Extended-release Buprenorphine in Mice after Surgical Catheterization.

Authors:  Marissa Saenz; Elizabeth A Bloom-Saldana; Tim Synold; Richard W Ermel; Patrick T Fueger; James B Finlay
Journal:  J Am Assoc Lab Anim Sci       Date:  2022-08-25       Impact factor: 1.706

2.  Regulation of OATP1B1 Function by Tyrosine Kinase-mediated Phosphorylation.

Authors:  Elizabeth R Hayden; Mingqing Chen; Kyle Z Pasquariello; Alice A Gibson; James J Petti; Shichen Shen; Jun Qu; Su Sien Ong; Taosheng Chen; Yan Jin; Muhammad Erfan Uddin; Kevin M Huang; Aviv Paz; Alex Sparreboom; Shuiying Hu; Jason A Sprowl
Journal:  Clin Cancer Res       Date:  2021-03-04       Impact factor: 12.531

3.  Intentional Modulation of Ibrutinib Pharmacokinetics through CYP3A Inhibition.

Authors:  Eric D Eisenmann; Qiang Fu; Elizabeth M Muhowski; Yan Jin; Muhammad Erfan Uddin; Dominique A Garrison; Robert H Weber; Jennifer Woyach; John C Byrd; Alex Sparreboom; Sharyn D Baker
Journal:  Cancer Res Commun       Date:  2021-11-09

4.  Development and validation of a UPLC-MS/MS analytical method for dofetilide in mouse plasma and urine, and its application to pharmacokinetic study.

Authors:  Muhammad Erfan Uddin; Xinxin Sun; Kevin M Huang; Shuiying Hu; Cynthia A Carnes; Alex Sparreboom; Qiang Fu
Journal:  J Pharm Biomed Anal       Date:  2019-04-19       Impact factor: 3.935

5.  Development, validation, and application of an LC-MS/MS method for the determination of the AXL/FLT3 inhibitor gilteritinib in mouse plasma.

Authors:  Dominique A Garrison; Yan Jin; Muhammad Erfan Uddin; Alex Sparreboom; Sharyn D Baker
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2021-07-30       Impact factor: 3.205

6.  Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter study.

Authors:  Ahmed El-Serafi; Rui He; Wenyi Zheng; Fadwa Benkossou; Sandra Oerther; Ying Zhao; Karin Mellgren; Britt Gustafsson; Carsten Heilmann; Jukka Kanerva; Kourosh Lotfi; Jacek Toporski; Mikael Sundin; Martin Höglund; Jonas Mattsson; Ibrahim El-Serafi; Moustapha Hassan
Journal:  Bone Marrow Transplant       Date:  2020-10-21       Impact factor: 5.483

7.  Rapid quantification of vincristine in mouse plasma using ESI-LC-MS/MS: Application to pharmacokinetic studies.

Authors:  Yan Jin; Yang Li; Muhammad Erfan Uddin; Alex Sparreboom; Shuiying Hu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2021-02-21       Impact factor: 3.318

8.  Role of equilibrative nucleoside transporter 1 (ENT1) in the disposition of cytarabine in mice.

Authors:  Jason T Anderson; Shuiying Hu; Qiang Fu; Sharyn D Baker; Alex Sparreboom
Journal:  Pharmacol Res Perspect       Date:  2019-12-02

9.  Influence of YES1 Kinase and Tyrosine Phosphorylation on the Activity of OCT1.

Authors:  Muhammad Erfan Uddin; Dominique A Garrison; Kyeongmin Kim; Yan Jin; Eric D Eisenmann; Kevin M Huang; Alice A Gibson; Zeping Hu; Alex Sparreboom; Shuiying Hu
Journal:  Front Pharmacol       Date:  2021-03-08       Impact factor: 5.810

10.  Role of Oatp2b1 in Drug Absorption and Drug-Drug Interactions.

Authors:  Mingqing Chen; Shuiying Hu; Yang Li; Alice A Gibson; Qiang Fu; Sharyn D Baker; Alex Sparreboom
Journal:  Drug Metab Dispos       Date:  2020-02-29       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.